# Quantum Computing Inc. (QUBT) — InvestMoat Analysis _Last analyzed: July 16, 2026_ _Asset class: equity · Canonical page: https://investmoat.com/stocks/qubt_ ## Scores | Dimension | Score (0–100) | | --- | --- | | Moat durability | 38 | | Growth trajectory | 54 | | Valuation | 63 | | **Composite** | **49** | | **Recommendation** | **Avoid** | Scores are computed deterministically from this asset’s data by the InvestMoat formula (see https://investmoat.com/llms.txt for methodology). Scores are not directly comparable across asset classes. ## Key stats - **Ticker:** QUBT (Nasdaq) - **Market Cap:** ~$1.8B ## Moat The weakest and most contested moat of the quantum pure-plays — a photonic/TFLN foundry thesis backed by ~$1.4B of cash but almost no organic revenue, acquisition-manufactured growth, and an active short-seller report alleging the foundry business is 'phantom.' A cash-rich option on photonic quantum, not yet a demonstrated business. ### The Contested Foundry Bet QUBT's case is a cash pile and a technology claim more than a proven franchise — and one pillar is publicly disputed. **Three** early, unproven pillars: - **Photonic / TFLN Technology:** QUBT's bet is thin-film lithium niobate photonics — chips and foundry services, Dirac entropy-computing machines, the EmuCore reservoir-computing device, and quantum cybersecurity. Photonics is a legitimate quantum modality, but QUBT's specific claims are early-stage and, unlike IonQ or D-Wave, are not yet backed by material revenue or independent, at-scale validation. - **Cash-Funded Acquisitions:** With ~$1.4B raised, QUBT has bought Lumina Semiconductor (~$110M), NuCrypt (~$5M), and NHanced Semiconductors (~$73M + earnout) to assemble a photonics/packaging stack. This is buying capability, not compounding a moat — the acquisitions inflate reported revenue but the organic business remains de minimis, and integrating disparate assets is itself a risk. - **Early Customer & Government Touchpoints:** A NASA subcontract (~$406K), a first quantum-cybersecurity sale to a top-5 US bank, an EmuCore sale to an automotive OEM, and a vibrometer sale to TU Delft are cited as validation. These are small, one-off touchpoints rather than a recurring book — and short-seller Iceberg Research has publicly questioned the reality and timing of some announced orders. **Moat verdict:** What durability QUBT can claim — scarce photonics/TFLN talent and any genuine foundry process IP — is AI-resilient, since AI cannot replicate the underlying fabrication physics. But the honest picture is that QUBT has the thinnest moat of the quantum pure-plays: most categories are N/A or weakened, organic revenue is de minimis (~$682K FY2025), headline growth is acquisition-manufactured, and an active Iceberg Research short report specifically disputes the reality of the foundry business and some announced orders. The ~$1.4B cash balance is real and provides a partial floor, but the operating thesis is unproven and contested. This is a cash-rich, high-risk option on photonic quantum — the lowest-conviction name of the four and one where the credibility questions must be resolved before the business can be underwritten. ## Growth QUBT is the hardest quantum pure-play to underwrite honestly: FY2025 revenue was roughly $682K, and the Q1 2026 jump to $3.7M came almost entirely from consolidating acquired businesses rather than organic demand. The company is cash-rich (~$1.4B) and has opened a TFLN foundry (Fab-1) with a Fab-2 planned, so the thesis is that photonic-chip fabrication and foundry services eventually generate real revenue — but that has not yet happened at any meaningful scale, and short-seller Iceberg Research has publicly alleged the foundry business 'will amount to nothing' and that some announced orders are exaggerated. Given de minimis organic revenue against a ~$1.8B market cap, growth here is a claim and an option on cash deployment, not a demonstrated trajectory. - **Revenue CAGR estimate:** 5–15% - **Primary type:** TAM expansion - **Margin trend:** compressing - **Key risk (severe):** QUBT carries specific, unresolved credibility risk: short-seller Iceberg Research has alleged in its 'Phantom Chip Foundry' reports that the TFLN foundry pivot is a rebrand of a long-running 'perma-scam' and that certain announced orders are false or exaggerated and timed around capital raises. Even setting the allegations aside, organic revenue remains ~$682K against a ~$1.8B market cap — so if the foundry fails to generate real, verifiable revenue, there is essentially no fundamental support beneath the stock. - **Drivers:** - Acquired Revenue (Lumina / NuCrypt / NHanced) — Q1 2026 revenue of $3.7M vs $39K YoY — almost entirely from consolidating acquisitions, not organic sales (accelerating) - TFLN Foundry Services (Fab-1 / Fab-2) — Tempe, AZ foundry opened 2025; the core revenue thesis — but unproven at scale and disputed by short-sellers (stable) - Organic Product Sales — FY2025 organic revenue ~$682K across Dirac, EmuCore, vibrometer, and QKD — de minimis and not yet recurring (decelerating) - **Score derivation:** Base 73 (~10% assumed durable organic CAGR off a near-nil base, 8–15% band) + 0 trajectory (headline revenue up on acquisitions, but organic demand near-nil/decelerating) − 4 margin (persistent operating losses, no organic margin) + 3 TAM expansion (foundry/photonics optionality) − 15 severe risk (de minimis organic revenue plus an active short report) = 57. ## Valuation At ~$8 (~$1.8B) QUBT trades at roughly 2,700× trailing revenue — the most extreme valuation-to-fundamentals ratio in the group — but with ~$1.4B of cash (~$6.2/share) providing an unusually large partial floor. The price sits just above our $7 base case and only a fraction of the way into an $18 bull case (near the thin ~$18 average target from ~6 analysts). The cash is real; almost everything above it is a bet that the disputed photonic-foundry thesis becomes a genuine business. Given the active short report and near-nil organic revenue, treat this as the lowest-conviction name of the four. **Fair value:** $7 (base) — near the ~$6.2/share cash value; the operating business carries little demonstrable worth until the foundry produces verifiable revenue — P/E is omitted — QUBT is loss-making (Q1 2026 net loss $4.1M; a prior-year 'profit' was a non-cash warrant gain) with de minimis revenue. Conventional sales multiples are almost meaningless at ~2,700× trailing; the more relevant frame is price-to-cash (~$1.8B cap vs ~$1.4B cash), which implies the market ascribes only a modest premium to the operating business itself. That premium, however, is exactly what short-sellers dispute. ## Price scenarios ### Bear — $3 The foundry thesis fails to produce verifiable revenue, short-seller allegations gain traction, and the stock compresses toward — or through — its cash value as dilution continues and confidence erodes. - Fab-1/Fab-2 foundry revenue fails to materialise at scale, validating the 'phantom foundry' critique - Further scrutiny of announced orders and continued equity issuance pressures the stock toward its ~$6/share cash value and below on lost confidence - Acquisition integration disappoints, and headline revenue growth is revealed as purely inorganic ### Base — $7 QUBT deploys its cash into the foundry and acquisitions, generates modest but real revenue, and the market values it at roughly its cash plus a small operating premium — the stock drifts near current levels amid persistent skepticism. - The TFLN foundry and acquired businesses produce some verifiable, recurring revenue, partially answering the credibility questions - The ~$1.4B cash balance anchors the valuation while the operating business is slowly built out - No major adverse resolution of the short-seller allegations, but no decisive vindication either ### Bull — $18 The photonic-foundry bet is vindicated: Fab-1/Fab-2 win real foundry customers, the acquisitions integrate into a coherent photonics stack, and the market re-rates QUBT as a legitimate photonic-quantum and TFLN play toward the thin analyst target. - TFLN foundry services sign verifiable, recurring commercial customers at meaningful volume - Lumina, NuCrypt, and NHanced integrate into a credible end-to-end photonics/packaging platform - Independent validation and audited revenue growth decisively rebut the short-seller thesis, unlocking a re-rating --- InvestMoat is an open-source research and education framework. Nothing here is financial advice. Past performance does not guarantee future results.